Danaher Corp. has acquired patient monitoring specialist Masimo for $9.9 billion to enhance its diagnostics portfolio, allowing Danaher access to Masimo's advanced sensor technology and AI-enabled monitoring, with Masimo operating as a standalone company within Danaher's diagnostics segment. The acquisition follows a challenging period for Masimo, including leadership changes and legal battles, and is expected to boost Danaher's diagnostics growth and profitability.
The acquisition of Masimo by Danaher for $9.9 billion underscores the growing strategic importance of advanced sensor technology and AI-enabled patient monitoring in the medtech sector. For professionals monitoring the healthtech and medtech industries, this deal highlights a significant investment trend toward enhancing diagnostics capabilities and scaling monitoring technologies globally, offering potential opportunities for innovation and partnerships in remote patient monitoring and AI-driven healthcare solutions.